A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
NCT06174766 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 324
Last updated 2025-06-12
Summary
A Multicenter, Randomized, Double-blind, Phase 3 Study to Evaluate the Efficacy and Safety of HGP2102 in patients with Essential Hypertension
Conditions
Interventions
- DRUG
-
HGP2102-1
Test drug
- DRUG
-
HGP2102-2
Test drug
- DRUG
-
RLD2209-1
Control drug
- DRUG
-
RLD2209-2
Control drug
Sponsors & Collaborators
-
Hanmi Pharmaceutical Company Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-10
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- South Korea
More Related Trials
-
A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
NCT04959305 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension
NCT06438172 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
NCT04074551 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
NCT03897868 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension
NCT01193101 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405
NCT02387554 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients
NCT05475665 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients
NCT03756103 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy
NCT02770261 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients
NCT05476354 ·Status: COMPLETED ·Phase: PHASE3
-
Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)
NCT00157963 ·Status: COMPLETED ·Phase: PHASE4
-
An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
NCT05413057 ·Status: RECRUITING
-
Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients
NCT00670566 ·Status: COMPLETED ·Phase: PHASE4
-
The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers
NCT04764201 ·Status: COMPLETED ·Phase: PHASE1
-
Essential Hypertension
NCT01264692 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
NCT01541943 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension
NCT06212648 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension
NCT06647745 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of Blood Pressure Control Achieved in Antihypertensive or Generic Drugs in Moderate to Severe Hypertensive Patients
NCT02853045 ·Status: COMPLETED ·Phase: PHASE4
-
S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets Achievement
NCT06130124 ·Status: UNKNOWN
-
Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
NCT00553865 ·Status: COMPLETED ·Phase: PHASE2
-
Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
NCT02238275 ·Status: COMPLETED
-
Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension
NCT07297797 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)
NCT01370655 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
NCT06826872 ·Status: RECRUITING ·Phase: PHASE2